Admission fasting blood glucose predicts 30‐day poor outcome in patients hospitalized for <scp>COVID</scp> ‐19 pneumonia
Bin Zhang, Shuyi Liu, Lu Zhang, Yuhao Dong, Shuixing Zhang
Abstract
The peer review history for this article is available at https://publons.com/publon/10.1111/dom.14132. Appendix S1 Comparison of baseline characteristics between poor outcome and good outcome groups Appendix S2 Receiver operating characteristic curve of FBG for predicting poor 30-day outcome. The optimal cutoff FBG for predicting poor 30-day outcome was ≥6.23 mmol/L, with a sensitivity of 75.6% and a specificity of 77.0%. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
Topics & Concepts
MedicineARDSPneumoniaCoronavirus disease 2019 (COVID-19)Septic shockInternal medicineOrgan dysfunctionIntensive care medicineViral pneumoniaLungEmergency medicineSepsisDiseaseInfectious disease (medical specialty)COVID-19 Clinical Research StudiesPancreatitis Pathology and TreatmentLong-Term Effects of COVID-19